BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37992978)

  • 1. Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cells.
    Behera C; Kaur Sandha K; Banjare N; Kumar Shukla M; Mudassir Ali S; Singh M; Gupta PN
    Int J Pharm; 2024 Jan; 649():123599. PubMed ID: 37992978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment.
    Kushwah V; Agrawal AK; Dora CP; Mallinson D; Lamprou DA; Gupta RC; Jain S
    Pharm Res; 2017 Nov; 34(11):2295-2311. PubMed ID: 28795274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy.
    Behl A; Sarwalia P; Kumar S; Behera C; Mintoo MJ; Datta TK; Gupta PN; Chhillar AK
    Mol Pharm; 2022 Jul; 19(7):2429-2440. PubMed ID: 35639628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
    DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
    J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
    Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
    Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line.
    Yu X; Song Y; Di Y; He H; Fu D; Jin C
    Sci Rep; 2016 Aug; 6():31539. PubMed ID: 27515795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.
    Yu X; Di Y; Xie C; Song Y; He H; Li H; Pu X; Lu W; Fu D; Jin C
    Int J Nanomedicine; 2015; 10():6825-34. PubMed ID: 26586944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer.
    Li L; Zhao SL; Yue GGL; Wong TP; Pu JX; Sun HD; Fung KP; Leung PC; Han QB; Lau CBS; Leung PS
    Phytomedicine; 2018 May; 44():56-64. PubMed ID: 29895493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
    Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
    Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
    Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
    Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine.
    Duong HQ; Hong YB; Kim JS; Lee HS; Yi YW; Kim YJ; Wang A; Zhao W; Cho CH; Seong YS; Bae I
    J Cell Mol Med; 2013 Oct; 17(10):1261-70. PubMed ID: 23855452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heptadecanoic Acid, an Odd-Chain Fatty Acid, Induces Apoptosis and Enhances Gemcitabine Chemosensitivity in Pancreatic Cancer Cells.
    Kim HY; Moon JY; Cho SK
    J Med Food; 2023 Mar; 26(3):201-210. PubMed ID: 36716276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
    Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
    Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of methylselenocysteine in combination chemotherapy with gemcitabine for improved anticancer efficacy.
    Behera C; Sandha KK; Banjare N; Malik SB; Tabassum M; Kumar R; Kumar A; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2022 Sep; 176():106238. PubMed ID: 35714943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.
    Ma T; Jiang JL; Qi WX; Chen JY; Xu HP
    Drug Des Devel Ther; 2022; 16():2395-2406. PubMed ID: 35923931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic investigation of synergistic interaction of tocopherol succinate with a quinoline-based inhibitor of mammalian target of rapamycin.
    Behera C; Kour J; Banjare N; Verma PK; Chashoo G; Sawant SD; Gupta PN
    J Pharm Pharmacol; 2022 Apr; 74(4):605-617. PubMed ID: 34468737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
    Yang Y; Tian W; Yang L; Zhang Q; Zhu M; Liu Y; Li J; Yang L; Liu J; Shen Y; Qi Z
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):93-103. PubMed ID: 32897433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion.
    Yu L; Chen M; Zhang R; Jin Z
    J BUON; 2019; 24(4):1581-1586. PubMed ID: 31646812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
    Yin N; Yu H; Zhang X; Lv X
    Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.